BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9360843)

  • 1. The pattern of p53 and p21WAF1/CIP1 immunoreactivity in non-Hodgkin's lymphomas predicts p53 gene status.
    Mansukhani MM; Osborne BM; Zhong J; Matsushima AY
    Diagn Mol Pathol; 1997 Aug; 6(4):222-8. PubMed ID: 9360843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p21WAF1/CIP1 and MDM2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: a p53+, MDM2-, p21-immunophenotype associated with missense p53 mutations.
    Villuendas R; Pezzella F; Gatter K; Algara P; Sánchez-Beato M; Martínez P; Martínez JC; Muñoz K; García P; Sánchez L; Kocialkowsky S; Campo E; Orradre JL; Piris MA
    J Pathol; 1997 Jan; 181(1):51-61. PubMed ID: 9072003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p21/WAF1 cyclin-kinase inhibitor expression in non-Hodgkin's lymphomas: a potential marker of p53 tumor-suppressor gene function.
    Chilosi M; Doglioni C; Magalini A; Inghirami G; Krampera M; Nadali G; Rahal D; Pedron S; Benedetti A; Scardoni M; Macrì E; Lestani M; Menestrina F; Pizzolo G; Scarpa A
    Blood; 1996 Nov; 88(10):4012-20. PubMed ID: 8916968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 protein expression in non-Hodgkin's lymphomas is infrequently related to p53 gene mutations.
    Oka T; Sarker AB; Teramoto N; Yoshino T; Akagi T
    Pathol Int; 1998 Jan; 48(1):15-21. PubMed ID: 9589459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of p53 and p21WAF1/CIP1 proteins in gastric and esophageal cancers: comparison with mutations of the p53 gene.
    Seta T; Imazeki F; Yokosuka O; Saisho H; Suzuki T; Koide Y; Isono K
    Dig Dis Sci; 1998 Feb; 43(2):279-89. PubMed ID: 9512119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma.
    Møller MB; Nielsen O; Pedersen NT
    Histopathology; 2002 Oct; 41(4):322-30. PubMed ID: 12383214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p21 expression in colorectal carcinomas: a study on 103 cases with analysis of p53 gene mutation/expression and clinic-pathological correlations.
    Girlando S; Slomp P; Caffo O; Amichetti M; Togni R; Dvornik G; Tomio L; Galligioni E; Dalla Palma P; Barbareschi M
    Virchows Arch; 1999 Dec; 435(6):559-65. PubMed ID: 10628797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of p21WAF1/CIP1 is unrelated to p53 tumour suppressor gene status in oral squamous cell carcinomas.
    Yook JI; Kim J
    Oral Oncol; 1998 May; 34(3):198-203. PubMed ID: 9692054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human non-Hodgkin's lymphomas overexpress a wild-type form of p53 which is a functional transcriptional activator of the cyclin-dependent kinase inhibitor p21.
    Maestro R; Gloghini A; Doglioni C; Piccinin S; Vukosavljevic T; Gasparotto D; Carbone A; Boiocchi M
    Blood; 1997 Apr; 89(7):2523-8. PubMed ID: 9116298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDM2 and p21WAF1/CIP1, wild-type p53-induced proteins, are regularly expressed by Sternberg-Reed cells in Hodgkin's disease.
    Sánchez-Beato M; Piris MA; Martínez-Montero JC; García JF; Villuendas R; García FJ; Orradre JL; Martínez P
    J Pathol; 1996 Sep; 180(1):58-64. PubMed ID: 8943816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations between p21 expression and clinicopathological findings, p53 gene and protein alterations, and survival in patients with endometrial carcinoma.
    Ito K; Sasano H; Matsunaga G; Sato S; Yajima A; Nasim S; Garret CT
    J Pathol; 1997 Nov; 183(3):318-24. PubMed ID: 9422988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of p53 protein in T- and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations.
    Petit B; Leroy K; Kanavaros P; Boulland ML; Druet-Cabanac M; Haioun C; Bordessoule D; Gaulard P
    Hum Pathol; 2001 Feb; 32(2):196-204. PubMed ID: 11230707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between mutations in p53 gene and protein expression in human lymphomas.
    Martinez-Delgado B; Robledo M; Arranz E; Infantes F; Echezarreta G; Marcos B; Sanz C; Rivas C; Benitez J
    Am J Hematol; 1997 May; 55(1):1-8. PubMed ID: 9136910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32).
    Louie DC; Offit K; Jaslow R; Parsa NZ; Murty VV; Schluger A; Chaganti RS
    Blood; 1995 Oct; 86(8):2892-9. PubMed ID: 7579380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the p53 gene are not limited to classic 'hot spots' and are not predictive of p53 protein expression in high-grade non-Hodgkin's lymphoma.
    Kocialkowski S; Pezzella F; Morrison H; Jones M; Laha S; Harris AL; Mason DY; Gatter KC
    Br J Haematol; 1995 Jan; 89(1):55-60. PubMed ID: 7833277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous p21WAF1/CIP1 status predicts the response of human tumor cells to wild-type p53 and p21WAF1/CIP1 overexpression.
    Kralj M; Husnjak K; Körbler T; Pavelić J
    Cancer Gene Ther; 2003 Jun; 10(6):457-67. PubMed ID: 12768191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of p53 mutations and the expression of p53 and p21WAF1/CIP1 protein in 15 cases of sebaceous carcinoma of the eyelid.
    Kiyosaki K; Nakada C; Hijiya N; Tsukamoto Y; Matsuura K; Nakatsuka K; Daa T; Yokoyama S; Imaizumi M; Moriyama M
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):7-11. PubMed ID: 19628749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced messenger RNA expression level of p21 CIP1 in human colorectal carcinoma tissues and its association with p53 gene mutation.
    Matsushita K; Kobayashi S; Kato M; Itoh Y; Okuyama K; Sakiyama S; Isono K
    Int J Cancer; 1996 Aug; 69(4):259-64. PubMed ID: 8797864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between the gene mutation of p53 and the protein expression of p53 and Ki-67 in non-Hodgkin's lymphomas.
    Kuze T; Nakamura N; Hashimoto Y; Hojo H; Abe M; Wakasa H
    Pathol Int; 1996 Feb; 46(2):130-6. PubMed ID: 10846560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.